Sanofi Canada Earns 2013 Outstanding Partner Award from London Drugs

Sanofi Canada, one of Canada’s leading healthcare companies, is pleased to announce that it has been selected for a 2013 Outstanding Partner of the Year Award in the Pharmacy category by retail giant London Drugs.

London Drugs, based in Western Canada, recognizes a select group of vendors who have gone above and beyond to address the needs of their customers through innovative products and services. Award recipients were honored during a ceremony Monday, November 5, at the Park Hyatt Hotel in Toronto.

Key criteria in the selection of winners included development of products/services that answer patient needs, innovative technology, design and marketing, and teamwork with the London Drugs Management Group.

Sanofi is a global integrated healthcare company focused on patients’ needs. The company is engaged in research, development, manufacturing and marketing of healthcare products that make a difference in patients’ lives.

“We are very proud of this recognition from London Drugs as it is a testament to Sanofi Canada’s commitment to innovation, service and collaboration,” says Jon Fairest, President and CEO of Sanofi Canada. “Our patient-centered approach is at the heart of everything we do, and by working with partners, such as London Drugs, we aim to respond to the healthcare needs of Canadians.”

For more information about Sanofi Canada, please visit www.sanofi.ca and follow us on Twitter @SanofiCanada.

About Sanofi

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi entities in Canada include Sanofi Canada (pharmaceuticals), Sanofi Pasteur (vaccines), Sanofi Consumer Health (health and beauty), Genzyme (rare diseases) and Merial (animal health). Together they employ more than 1,700 people across the country. In 2012 Sanofi companies invested $122 million in R&D in Canada, creating jobs, business and opportunity throughout the country.

About London Drugs

London Drugs, www.londondrugs.com, has 78 stores in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan and Manitoba including its online store www.londondrugs.com. London Drugs offers consumers a range of products from digital cameras and cosmetics to computers and televisions. Renowned for its creative approach to retailing, the company employs more than 7,500 people with pharmacy and health care services being the heart of its business. Committed to innovation and superior customer service, London Drugs has established itself as a reputable and caring company and continues to position itself for future growth and development.